211 related articles for article (PubMed ID: 29659011)
1. Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study.
Shafiee A; McGovern JA; Lahr CA; Meinert C; Moi D; Wagner F; Landgraf M; De-Juan-Pardo E; Mazzieri R; Hutmacher DW
Int J Cancer; 2018 Sep; 143(6):1470-1482. PubMed ID: 29659011
[TBL] [Abstract][Full Text] [Related]
2. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
[TBL] [Abstract][Full Text] [Related]
3. Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma.
Wagner F; Holzapfel BM; McGovern JA; Shafiee A; Baldwin JG; Martine LC; Lahr CA; Wunner FM; Friis T; Bas O; Boxberg M; Prodinger PM; Shokoohmand A; Moi D; Mazzieri R; Loessner D; Hutmacher DW
Biomaterials; 2018 Jul; 171():230-246. PubMed ID: 29705656
[TBL] [Abstract][Full Text] [Related]
4. A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone.
Thibaudeau L; Taubenberger AV; Holzapfel BM; Quent VM; Fuehrmann T; Hesami P; Brown TD; Dalton PD; Power CA; Hollier BG; Hutmacher DW
Dis Model Mech; 2014 Feb; 7(2):299-309. PubMed ID: 24713276
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
[TBL] [Abstract][Full Text] [Related]
6. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.
Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A
Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680
[TBL] [Abstract][Full Text] [Related]
7. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
[TBL] [Abstract][Full Text] [Related]
8. Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone.
Kähkönen TE; Suominen MI; Mäki-Jouppila JHE; Halleen JM; Tanaka A; Seiler M; Bernoulli J
J Immunol Res; 2019; 2019():4260987. PubMed ID: 31211147
[TBL] [Abstract][Full Text] [Related]
9. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
[TBL] [Abstract][Full Text] [Related]
10. Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.
Reggiani F; Labanca V; Mancuso P; Rabascio C; Talarico G; Orecchioni S; Manconi A; Bertolini F
Cancer Res; 2017 Sep; 77(18):5169-5182. PubMed ID: 28754674
[TBL] [Abstract][Full Text] [Related]
11. A humanised tissue-engineered bone model allows species-specific breast cancer-related bone metastasis in vivo.
Quent V; Taubenberger AV; Reichert JC; Martine LC; Clements JA; Hutmacher DW; Loessner D
J Tissue Eng Regen Med; 2018 Feb; 12(2):494-504. PubMed ID: 28714574
[TBL] [Abstract][Full Text] [Related]
12. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
[TBL] [Abstract][Full Text] [Related]
13. Effects of VEGFR1
Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
[TBL] [Abstract][Full Text] [Related]
14. Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.
García-García A; Klein T; Born G; Hilpert M; Scherberich A; Lengerke C; Skoda RC; Bourgine PE; Martin I
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34580200
[TBL] [Abstract][Full Text] [Related]
15. Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues.
Moioli EK; Clark PA; Chen M; Dennis JE; Erickson HP; Gerson SL; Mao JJ
PLoS One; 2008; 3(12):e3922. PubMed ID: 19081793
[TBL] [Abstract][Full Text] [Related]
16. Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patients.
Werner-Klein M; Proske J; Werno C; Schneider K; Hofmann HS; Rack B; Buchholz S; Ganzer R; Blana A; Seelbach-Göbel B; Nitsche U; Männel DN; Klein CA
PLoS One; 2014; 9(5):e97860. PubMed ID: 24830425
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
18. Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions.
Holen I; Nutter F; Wilkinson JM; Evans CA; Avgoustou P; Ottewell PD
Clin Exp Metastasis; 2015 Oct; 32(7):689-702. PubMed ID: 26231669
[TBL] [Abstract][Full Text] [Related]
19. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
